SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-170431
Filing Date
2021-05-24
Accepted
2021-05-24 12:54:01
Documents
12
Period of Report
2021-05-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d187465d8k.htm   iXBRL 8-K 39111
  Complete submission text file 0001193125-21-170431.txt   158481

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210520.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210520_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210520_pre.xml EX-101.PRE 10968
5 EXTRACTED XBRL INSTANCE DOCUMENT d187465d8k_htm.xml XML 3231
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 21952618
SIC: 2834 Pharmaceutical Preparations